Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $752.64 | 33 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| OptiNose US, Inc. | $277.00 | 13 | $0 (2022) |
| Regeneron Healthcare Solutions, Inc. | $122.10 | 1 | $0 (2019) |
| Aerin Medical Inc. | $48.37 | 1 | $0 (2019) |
| Lannett Company Inc | $38.06 | 2 | $0 (2017) |
| Phadia US Inc. | $34.45 | 2 | $0 (2019) |
| ARBOR PHARMACEUTICALS, INC. | $34.44 | 2 | $0 (2018) |
| Ethicon US, LLC | $22.09 | 1 | $0 (2018) |
| Galderma Laboratories, L.P. | $21.67 | 1 | $0 (2017) |
| Stryker Corporation | $21.05 | 1 | $0 (2019) |
| VYNE Pharmaceuticals Inc. | $20.16 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $21.38 | 1 | OptiNose US, Inc. ($21.38) |
| 2021 | $104.31 | 5 | Optinose US, Inc. ($84.15) |
| 2020 | $93.82 | 5 | OptiNose US, Inc. ($61.18) |
| 2019 | $367.48 | 13 | Regeneron Healthcare Solutions, Inc. ($122.10) |
| 2018 | $76.21 | 4 | Optinose US, Inc. ($22.30) |
| 2017 | $89.44 | 5 | Lannett Company Inc ($38.06) |
All Payment Transactions
33 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/09/2022 | OptiNose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $21.38 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 08/13/2021 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $22.26 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 05/26/2021 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $14.18 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 03/19/2021 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $23.80 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 02/19/2021 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $23.91 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 01/19/2021 | VYNE Pharmaceuticals Inc. | ZILXI (Drug) | Food and Beverage | In-kind items and services | $20.16 | General |
| Category: Treatment of Rosacea | ||||||
| 12/11/2020 | OptiNose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $19.73 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 11/19/2020 | OptiNose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $22.67 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 09/17/2020 | Intersect ENT, Inc. | PROPEL (Device) | Food and Beverage | In-kind items and services | $18.41 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 06/30/2020 | Tactile Systems Technology Inc | FLEXITOUCH (Device), ACTITOUCH, ENTRE | Food and Beverage | In-kind items and services | $14.23 | General |
| Category: PNEUMATIC COMPRESSOR | ||||||
| 05/14/2020 | OptiNose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $18.78 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 12/13/2019 | OptiNose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $20.40 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 11/08/2019 | OptiNose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $21.22 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 11/01/2019 | OptiNose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $23.70 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 10/29/2019 | Phadia US Inc. | ImmunoCAP (Device) | Food and Beverage | Cash or cash equivalent | $17.66 | General |
| Category: Allergy/Immunology | ||||||
| 09/11/2019 | OptiNose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $22.67 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 08/15/2019 | Celgene Corporation | — | Food and Beverage | In-kind items and services | $12.60 | General |
| 08/13/2019 | Phadia US Inc. | ImmunoCAP (Device) | Food and Beverage | Cash or cash equivalent | $16.79 | General |
| Category: Allergy/Immunology | ||||||
| 08/01/2019 | Glenmark Therapeutics Inc. | Otiprio (Drug) | Food and Beverage | Cash or cash equivalent | $13.00 | General |
| Category: Antibiotic | ||||||
| 04/03/2019 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $122.10 | General |
| Category: ONCOLOGY | ||||||
| 03/28/2019 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $15.27 | General |
| Category: Virology & Specialty Care | ||||||
| 02/22/2019 | EPI Health, LLC | Sitavig (Drug), Cloderm, Minolira 105mg | Food and Beverage | Cash or cash equivalent | $12.65 | General |
| Category: Dermatology | ||||||
| 02/08/2019 | Stryker Corporation | SPIROX - LATERA (Device) | Food and Beverage | Cash or cash equivalent | $21.05 | General |
| Category: SPIROX | ||||||
| 01/22/2019 | Aerin Medical Inc. | Vivaer RF Stylus (Device) | Food and Beverage | Cash or cash equivalent | $48.37 | General |
| Category: Ear, Nose & Throat | ||||||
| 11/12/2018 | Checkpoint Surgical, Inc | Checkpoint Stimulators (Device) | Food and Beverage | In-kind items and services | $10.93 | General |
| Category: Surgery | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 325 | 445 | $124,741 | $30,064 |
| 2022 | 10 | 498 | 723 | $210,894 | $60,744 |
| 2021 | 7 | 347 | 510 | $358,939 | $41,882 |
| 2020 | 9 | 471 | 646 | $291,877 | $41,918 |
All Medicare Procedures & Services
34 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 55 | 77 | $25,025 | $7,648 | 30.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 75 | 118 | $40,275 | $7,505 | 18.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 56 | 56 | $19,600 | $4,481 | 22.9% |
| 69210 | Removal of impacted ear wax | Office | 2023 | 71 | 116 | $17,400 | $4,328 | 24.9% |
| 31575 | Diagnostic exam of voice box using a flexible endoscope | Office | 2023 | 23 | 27 | $11,988 | $3,047 | 25.4% |
| 31231 | Diagnostic exam of nasal passages using an endoscope | Office | 2023 | 14 | 14 | $6,300 | $2,192 | 34.8% |
| 92553 | Test for hearing various pitches using earphone and device placed against the bone | Office | 2023 | 14 | 18 | $2,538 | $612.15 | 24.1% |
| 92550 | Test for eardrum and muscle function | Office | 2023 | 17 | 19 | $1,615 | $251.55 | 15.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 134 | 242 | $78,650 | $25,347 | 32.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 85 | 85 | $29,350 | $7,653 | 26.1% |
| 31575 | Diagnostic exam of voice box using a flexible endoscope | Office | 2022 | 51 | 62 | $27,528 | $6,827 | 24.8% |
| 69210 | Removal of impacted ear wax | Office | 2022 | 94 | 151 | $22,650 | $5,729 | 25.3% |
| 31231 | Diagnostic exam of nasal passages using an endoscope | Office | 2022 | 23 | 29 | $13,050 | $4,959 | 38.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 47 | 60 | $22,300 | $4,340 | 19.5% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2022 | 18 | 28 | $8,340 | $3,741 | 44.9% |
| 95992 | Repositioning exercises of head for treatment of dizziness, each day | Office | 2022 | 15 | 28 | $4,620 | $1,066 | 23.1% |
| 92553 | Test for hearing various pitches using earphone and device placed against the bone | Office | 2022 | 19 | 21 | $2,961 | $766.70 | 25.9% |
| 92550 | Test for eardrum and muscle function | Office | 2022 | 12 | 17 | $1,445 | $314.96 | 21.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 121 | 224 | $130,000 | $23,013 | 17.7% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 59 | 59 | $32,700 | $5,042 | 15.4% |
| 31575 | Diagnostic examination of voice box using flexible endoscope | Office | 2021 | 34 | 42 | $53,912 | $4,954 | 9.2% |
| 69210 | Removal of impact ear wax, one ear | Office | 2021 | 85 | 135 | $87,425 | $4,768 | 5.5% |
| 31231 | Diagnostic examination of nasal passages using an endoscope | Office | 2021 | 18 | 18 | $27,500 | $3,254 | 11.8% |
| 92553 | Pure tone air and bone conduction hearing assessment | Office | 2021 | 15 | 16 | $17,082 | $564.00 | 3.3% |
| 92550 | Assessment of eardrum and muscle function | Office | 2021 | 15 | 16 | $10,320 | $287.84 | 2.8% |
About Dr. Raphael Nach, MD
Dr. Raphael Nach, MD is a Otolaryngology healthcare provider based in Beverly Hills, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/16/2006. The National Provider Identifier (NPI) number assigned to this provider is 1851497713.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Raphael Nach, MD has received a total of $752.64 in payments from pharmaceutical and medical device companies, with $21.38 received in 2022. These payments were reported across 33 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($752.64).
As a Medicare-enrolled provider, Nach has provided services to 1,641 Medicare beneficiaries, totaling 2,324 services with total Medicare billing of $174,608. Data is available for 4 years (2020–2023), covering 34 distinct procedure/service records.
Practice Information
- Specialty Otolaryngology
- Location Beverly Hills, CA
- Active Since 09/16/2006
- Last Updated 03/22/2017
- Taxonomy Code 207Y00000X
- Entity Type Individual
- NPI Number 1851497713
Products in Payments
- Xhance (Drug) $277.00
- LIBTAYO (Biological) $122.10
- Vivaer RF Stylus (Device) $48.37
- C Topical Solution 4 CII (Drug) $38.06
- ImmunoCAP (Device) $34.45
- Otovel (Drug) $34.44
- LINX Reflux Management System (Device) $22.09
- SPIROX - LATERA (Device) $21.05
- ZILXI (Drug) $20.16
- PROPEL (Device) $18.41
- XprESS Multi-Sinus Dilation System (Device) $16.16
- Xofluza (Drug) $15.27
- FLEXITOUCH (Device) $14.23
- Otiprio (Drug) $13.00
- Sitavig (Drug) $12.65
- Checkpoint Stimulators (Device) $10.93
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Otolaryngology Doctors in Beverly Hills
Dr. Benjamin Rafii, M.d, M.D
Otolaryngology — Payments: $6,130
Dr. Vivek-Sagar Patel, M.d, M.D
Otolaryngology — Payments: $4,301
Andrew Berman, Md, MD
Otolaryngology — Payments: $3,939
Dr. Ronen Nazarian, M.d, M.D
Otolaryngology — Payments: $2,051
Dr. Marc Kayem, Md, MD
Otolaryngology — Payments: $1,853
Sohit Kanotra, M.d, M.D
Otolaryngology — Payments: $1,313